Martha Raluca Neagu
Affiliations: | Harvard University, Cambridge, MA, United States |
Area:
brain tumorsGoogle:
"Martha Neagu"Mean distance: 106866
Parents
Sign in to add mentor| Jeremy Luban | grad student | 2009 | Columbia (Microtree) | |
| (HIV -1 inhibition by human TRIM5-Cyp fusion proteins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pizzato M, McCauley SM, Neagu MR, et al. (2015) Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration. Plos Pathogens. 11: e1005050 |
| Pizzato M, Neagu M, Pertel T, et al. (2013) Lv4, an activity that restricts nuclear entry of SIVMAC/SIVSM in human blood cells Retrovirology. 10: O28 |
| Neagu MR, Ziegler P, Pertel T, et al. (2009) Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. The Journal of Clinical Investigation. 119: 3035-47 |
| Pertel T, Neagu MR, Hausman S, et al. (2009) TRIM5alpha contributes to the anti-viral state Retrovirology. 6: O6 |
| Zhu C, Wang X, Deinum J, et al. (2007) Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. The Journal of Experimental Medicine. 204: 1741-8 |
| Colgan J, Asmal M, Neagu M, et al. (2004) Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity. 21: 189-201 |